On May 9, 2019 the Food and Drug Administration issued a “Recommendations for Reducing the Risk of Transfusion-Transmitted Babesiosis” guidance document with a maximum 12 month implementation timeline. Per the FDA guidance document recommendations, CTS is developing a specific implementation plan for mandatory Babesia testing well before the May 8, 2020 deadline.
Check out the Communication page for the complete details by clicking the link: Communications
CTS will be revising some forms in use by clients on October 26, 2020. We do try to limit form chang...
The CTS Medical Advisory Board recently agreed upon a revision to our standard testing algorithm. Th...
The CTS Medical Advisory Board recently agreed upon a revision to our standard testing algorithm thi...
Currently, there are limited supplies of the reagents used for HIV-1 Western Blot and HIV-2 EIA test...
On April 29, 2019, CTS will begin performing Donor-Screen HLA® Class I and II testing on the Str...
On February 18, 2019, the new CTS Laboratory Information System was successfully implemented in Tamp...